Cargando…
Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker
Objectives: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) occurs due to abnormal proliferation of pulmonary neuroendocrine cells. We hypothesized that performing a quantitative analysis of airway features on chest CT may reveal differences to matched controls, which could ul...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776594/ https://www.ncbi.nlm.nih.gov/pubmed/36553103 http://dx.doi.org/10.3390/diagnostics12123096 |
_version_ | 1784855904077742080 |
---|---|
author | O’Brien, Cormac Duignan, John A. Gleeson, Margaret O’Carroll, Orla Franciosi, Alessandro N. O’Toole, Dermot Fabre, Aurelie Crowley, Rachel K. McCarthy, Cormac Dodd, Jonathan D. Murphy, David J. |
author_facet | O’Brien, Cormac Duignan, John A. Gleeson, Margaret O’Carroll, Orla Franciosi, Alessandro N. O’Toole, Dermot Fabre, Aurelie Crowley, Rachel K. McCarthy, Cormac Dodd, Jonathan D. Murphy, David J. |
author_sort | O’Brien, Cormac |
collection | PubMed |
description | Objectives: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) occurs due to abnormal proliferation of pulmonary neuroendocrine cells. We hypothesized that performing a quantitative analysis of airway features on chest CT may reveal differences to matched controls, which could ultimately help provide an imaging biomarker. Methods: A retrospective quantitative analysis of chest CTs in patients with DIPNECH and age matched controls was carried out using semi-automated post-processing software. Paired segmental airway and artery diameters were measured for each bronchopulmonary segment, and the airway:artery (AA) ratio, airway wall thickness:artery ratio (AWTA ratio) and wall area percentage (WAP) calculated. Nodule number, size, shape and location was recorded. Correlation between CT measurements and pulmonary function testing was performed. Results: 16 DIPNECH and 16 control subjects were analysed (all female, mean age 61.7 +/− 11.8 years), a combined total of 425 bronchopulmonary segments. The mean AwtA ratio, AA ratio and WAP for the DIPNECH group was 0.57, 1.18 and 68.8%, respectively, compared with 0.38, 1.03 and 58.3% in controls (p < 0.001, <0.001, 0.03, respectively). DIPNECH patients had more nodules than controls (22.4 +/− 32.6 vs. 3.6 +/− 3.6, p = 0.03). AA ratio correlated with FVC (R2 = 0.47, p = 0.02). A multivariable model incorporating nodule number, AA ratio and AWTA-ratio demonstrated good performance for discriminating DIPNECH and controls (AUC 0.971; 95% CI: 0.925–1.0). Conclusions: Quantitative CT airway analysis in patients with DIPNECH demonstrates increased airway wall thickness and airway:artery ratio compared to controls. Advances in knowledge: Quantitative CT measurement of airway wall thickening offers a potential imaging biomarker for treatment response. |
format | Online Article Text |
id | pubmed-9776594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97765942022-12-23 Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker O’Brien, Cormac Duignan, John A. Gleeson, Margaret O’Carroll, Orla Franciosi, Alessandro N. O’Toole, Dermot Fabre, Aurelie Crowley, Rachel K. McCarthy, Cormac Dodd, Jonathan D. Murphy, David J. Diagnostics (Basel) Article Objectives: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) occurs due to abnormal proliferation of pulmonary neuroendocrine cells. We hypothesized that performing a quantitative analysis of airway features on chest CT may reveal differences to matched controls, which could ultimately help provide an imaging biomarker. Methods: A retrospective quantitative analysis of chest CTs in patients with DIPNECH and age matched controls was carried out using semi-automated post-processing software. Paired segmental airway and artery diameters were measured for each bronchopulmonary segment, and the airway:artery (AA) ratio, airway wall thickness:artery ratio (AWTA ratio) and wall area percentage (WAP) calculated. Nodule number, size, shape and location was recorded. Correlation between CT measurements and pulmonary function testing was performed. Results: 16 DIPNECH and 16 control subjects were analysed (all female, mean age 61.7 +/− 11.8 years), a combined total of 425 bronchopulmonary segments. The mean AwtA ratio, AA ratio and WAP for the DIPNECH group was 0.57, 1.18 and 68.8%, respectively, compared with 0.38, 1.03 and 58.3% in controls (p < 0.001, <0.001, 0.03, respectively). DIPNECH patients had more nodules than controls (22.4 +/− 32.6 vs. 3.6 +/− 3.6, p = 0.03). AA ratio correlated with FVC (R2 = 0.47, p = 0.02). A multivariable model incorporating nodule number, AA ratio and AWTA-ratio demonstrated good performance for discriminating DIPNECH and controls (AUC 0.971; 95% CI: 0.925–1.0). Conclusions: Quantitative CT airway analysis in patients with DIPNECH demonstrates increased airway wall thickness and airway:artery ratio compared to controls. Advances in knowledge: Quantitative CT measurement of airway wall thickening offers a potential imaging biomarker for treatment response. MDPI 2022-12-08 /pmc/articles/PMC9776594/ /pubmed/36553103 http://dx.doi.org/10.3390/diagnostics12123096 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article O’Brien, Cormac Duignan, John A. Gleeson, Margaret O’Carroll, Orla Franciosi, Alessandro N. O’Toole, Dermot Fabre, Aurelie Crowley, Rachel K. McCarthy, Cormac Dodd, Jonathan D. Murphy, David J. Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker |
title | Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker |
title_full | Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker |
title_fullStr | Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker |
title_full_unstemmed | Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker |
title_short | Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker |
title_sort | quantitative airway assessment of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (dipnech) on ct as a novel biomarker |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776594/ https://www.ncbi.nlm.nih.gov/pubmed/36553103 http://dx.doi.org/10.3390/diagnostics12123096 |
work_keys_str_mv | AT obriencormac quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker AT duignanjohna quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker AT gleesonmargaret quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker AT ocarrollorla quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker AT franciosialessandron quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker AT otooledermot quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker AT fabreaurelie quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker AT crowleyrachelk quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker AT mccarthycormac quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker AT doddjonathand quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker AT murphydavidj quantitativeairwayassessmentofdiffuseidiopathicpulmonaryneuroendocrinecellhyperplasiadipnechonctasanovelbiomarker |